GlaxoSmithKline Recalls Inhalers

GlaxoSmithKline is voluntarily recalling their Ventolin HFA Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations because of a defective delivery system, according to the FDA.

Some canisters may not contain sufficient propellant to deliver the labeled claim of 200 actuations through the end of shelf life.

This is a Class II recall and impacts more than 128,000 devices.